Lumbab, Maricel M.

HRN: 21-65-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2022
METRONIDAZOLE 500MG (TAB)
07/28/2022
08/05/2022
PO
500mg
Q8
Amoebiasis
Waiting Final Action 
08/02/2022
CEFUROXIME 1.5GM (VIAL)
08/02/2022
08/03/2022
IV
1.5 Grams
Loading Dose
STAT CS
Waiting Final Action 
08/02/2022
CEFUROXIME 1.5GM (VIAL)
08/02/2022
08/03/2022
IV
1.5 Gms X 3 Doses
Q 8 HRS
S/P LTCS
Waiting Final Action 
08/03/2022
CEFUROXIME 500MG (TAB)
08/03/2022
08/03/2022
PO
500mg
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: